BIOMAXIMA SA ZY 1
BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements. The company also provides molecular biology and cell culture products which includes real time PCR, nucleic acid… Read more
BIOMAXIMA SA ZY 1 (944) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, BIOMAXIMA SA ZY 1 (944) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
BIOMAXIMA SA ZY 1 - Net Assets Trend (None–None)
This chart illustrates how BIOMAXIMA SA ZY 1's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BIOMAXIMA SA ZY 1 (None–None)
The table below shows the annual net assets of BIOMAXIMA SA ZY 1 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to BIOMAXIMA SA ZY 1's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
BIOMAXIMA SA ZY 1 Competitors by Market Cap
The table below lists competitors of BIOMAXIMA SA ZY 1 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Korfez Gayrimenkul Yatirim
IS:KRGYO
|
$6.51 Million |
|
Landmarks Bhd
KLSE:1643
|
$6.51 Million |
|
Chibougamau Independent Mines Inc
PINK:CMAUF
|
$6.52 Million |
|
Nexalin Technology Inc.
NASDAQ:NXL
|
$6.52 Million |
|
Yuasa Battery (Thailand) Public Company Limited
BK:YUASA
|
$6.51 Million |
|
Diversified Gateway Solutions Bhd
KLSE:0131
|
$6.51 Million |
|
Intelligent Bio Solutions Inc.
NASDAQ:INBS
|
$6.50 Million |
|
CXApp Inc.
NASDAQ:CXAI
|
$6.50 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BIOMAXIMA SA ZY 1's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares BIOMAXIMA SA ZY 1's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently BIOMAXIMA SA ZY 1 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares BIOMAXIMA SA ZY 1's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $10,792,710,184
- Average return on equity (ROE) among peers: -33.38%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BIOMAXIMA SA ZY 1 (944) | €- | N/A | N/A | $6.51 Million |
| Spermosens AB (publ) (9R5) | $23.64 Million | -27.17% | 0.09x | $517.28K |
| BML Inc (BMZ) | $81.13 Billion | 8.19% | 0.43x | $462.01 Million |
| Genomic Vision Société Anonyme (G09) | $3.07 Million | -162.85% | 1.21x | $711.54K |
| ICON Public Limited Company (IJF) | $1.85 Billion | 17.96% | 0.86x | $6.43 Billion |
| Adicon Holdings Limited (K0U) | $1.77 Billion | 2.65% | 1.64x | $138.53 Million |
| WuXi XDC Cayman Inc. (L74) | $1.48 Billion | 10.52% | 0.69x | $2.11 Billion |
| NanoRepro AG (NN6) | $57.61 Million | 51.59% | 0.37x | $16.84 Million |
| PERRIGO (PGO) | $24.67 Million | -167.93% | 0.99x | $6.37K |